Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Randomised Phase II Pilot Study: Induction Chemotherapy With Docetaxel, Cisplatin and Cetuximab Versus Docetaxel, Cisplatin and 5 FU Followed by Radiotherapy With Cetuximab for Locally Advanced or Not Resectable Carcinoma of the Head and Neck

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01884259
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:38.369612+00:00
Published At
2022-05-26T00:00:00+00:00
Record Updated At
2022-05-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Squamous Cell Carcinoma of the Hypopharynx Stage III", "Squamous Cell Carcinoma of the Hypopharynx Stage IV", "Squamous Cell Carcinoma of the Larynx Stage III", "Squamous Cell Carcinoma of the Larynx Stage IV", "Squamous Cell Carcinoma of the Oropharynx Stage III", "Squamous Cell Carcinoma of the Oropharynx Stage IV", "Squamous Cell Carcinoma of the Oral Cavity Stage III", "Squamous Cell Carcinoma of the Oral Cavity Stage IV"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-05-26"
protocolSection.identificationModule.nctId
"NCT01884259"
protocolSection.identificationModule.officialTitle
"Randomised Phase II Pilot Study: Induction Chemotherapy With Docetaxel, Cisplatin and Cetuximab Versus Docetaxel, Cisplatin and 5 FU Followed by Radiotherapy With Cetuximab for Locally Advanced or Not Resectable Carcinoma of the Head and Neck"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Squamous Cell Carcinoma of the Hypopharynx Stage III (protocolSection.conditionsModule.conditions)
  • Squamous Cell Carcinoma of the Hypopharynx Stage IV (protocolSection.conditionsModule.conditions)
  • Squamous Cell Carcinoma of the Larynx Stage III (protocolSection.conditionsModule.conditions)
  • Squamous Cell Carcinoma of the Larynx Stage IV (protocolSection.conditionsModule.conditions)
  • Squamous Cell Carcinoma of the Oropharynx Stage III (protocolSection.conditionsModule.conditions)
  • Squamous Cell Carcinoma of the Oropharynx Stage IV (protocolSection.conditionsModule.conditions)
  • Squamous Cell Carcinoma of the Oral Cavity Stage III (protocolSection.conditionsModule.conditions)
  • Squamous Cell Carcinoma of the Oral Cavity Stage IV (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.